Effect of interleukin-1β and tumor necrosis factor-α on the expression of G-proteins in CD4+ T-cells of atopic asthmatic subjects

Matthew H. Kim, Devendra K. Agrawal

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Chronic use of β2-agonists and increased production of inflammatory mediators during the late allergic reaction after the antigen challenge result in the desensitization of β-adrenoceptors in the airways with an accompanying rise in non-specific airway hyperresponsiveness. Several proinflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), play a significant role in orchestrating and perpetuating the inflammatory response and induce the decreased response to bronchodilators in vitro. However, the underlying mechanisms are unknown. In this study, we examined the effect of two cytokines, IL-1β and TNF-α, on the expression of guanine nucleotide binding regulatory proteins (G-proteins), Gsα and Giα-3, by Western blotting in the CD4+ cells of nonatopic nonasthmatic (NANA), atopic nonasthmatic (ANA), and atopic asthmatic (AA) subjects. In the purified CD4+ cells, the basal expression of Gsα was higher in the ANA group, and significantly lower in the AA group as compared to the NANA group. The basal expression of Giα-3 was significantly greater (3-15 fold) than Gsα, with no significant difference between any of the three groups. Both cytokines IL-1β and TNF-α significantly decreased the expression of Gsα in the CD4+ cells of the NANA and ANA groups, with no effect in the AA group. However, these cytokines increased the expression of Giα-3, proteins in the AA group, but had no effect in the CD4+ cells of the NANA and ANA groups. These data suggest that a decreased response to β2agonists in the late allergic response in allergis asthmatic subjects could be due to the release of inflammatory cytokines, which induce a decrease in the stimulatory G-proteins and an increase in the inhibitory G-proteins.

Original languageEnglish
Pages (from-to)441-448
Number of pages8
JournalJournal of Asthma
Volume39
Issue number5
DOIs
StatePublished - 2002

Fingerprint

Interleukin-1
GTP-Binding Proteins
Carrier Proteins
Tumor Necrosis Factor-alpha
Cytokines
T-Lymphocytes
Bronchodilator Agents
Adrenergic Receptors
Hypersensitivity
Western Blotting
Antigens
Proteins

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

@article{34286b92b1e742d7bbe6a4863fa5aab8,
title = "Effect of interleukin-1β and tumor necrosis factor-α on the expression of G-proteins in CD4+ T-cells of atopic asthmatic subjects",
abstract = "Chronic use of β2-agonists and increased production of inflammatory mediators during the late allergic reaction after the antigen challenge result in the desensitization of β-adrenoceptors in the airways with an accompanying rise in non-specific airway hyperresponsiveness. Several proinflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), play a significant role in orchestrating and perpetuating the inflammatory response and induce the decreased response to bronchodilators in vitro. However, the underlying mechanisms are unknown. In this study, we examined the effect of two cytokines, IL-1β and TNF-α, on the expression of guanine nucleotide binding regulatory proteins (G-proteins), Gsα and Giα-3, by Western blotting in the CD4+ cells of nonatopic nonasthmatic (NANA), atopic nonasthmatic (ANA), and atopic asthmatic (AA) subjects. In the purified CD4+ cells, the basal expression of Gsα was higher in the ANA group, and significantly lower in the AA group as compared to the NANA group. The basal expression of Giα-3 was significantly greater (3-15 fold) than Gsα, with no significant difference between any of the three groups. Both cytokines IL-1β and TNF-α significantly decreased the expression of Gsα in the CD4+ cells of the NANA and ANA groups, with no effect in the AA group. However, these cytokines increased the expression of Giα-3, proteins in the AA group, but had no effect in the CD4+ cells of the NANA and ANA groups. These data suggest that a decreased response to β2agonists in the late allergic response in allergis asthmatic subjects could be due to the release of inflammatory cytokines, which induce a decrease in the stimulatory G-proteins and an increase in the inhibitory G-proteins.",
author = "Kim, {Matthew H.} and Agrawal, {Devendra K.}",
year = "2002",
doi = "10.1081/JAS-120004037",
language = "English",
volume = "39",
pages = "441--448",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Effect of interleukin-1β and tumor necrosis factor-α on the expression of G-proteins in CD4+ T-cells of atopic asthmatic subjects

AU - Kim, Matthew H.

AU - Agrawal, Devendra K.

PY - 2002

Y1 - 2002

N2 - Chronic use of β2-agonists and increased production of inflammatory mediators during the late allergic reaction after the antigen challenge result in the desensitization of β-adrenoceptors in the airways with an accompanying rise in non-specific airway hyperresponsiveness. Several proinflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), play a significant role in orchestrating and perpetuating the inflammatory response and induce the decreased response to bronchodilators in vitro. However, the underlying mechanisms are unknown. In this study, we examined the effect of two cytokines, IL-1β and TNF-α, on the expression of guanine nucleotide binding regulatory proteins (G-proteins), Gsα and Giα-3, by Western blotting in the CD4+ cells of nonatopic nonasthmatic (NANA), atopic nonasthmatic (ANA), and atopic asthmatic (AA) subjects. In the purified CD4+ cells, the basal expression of Gsα was higher in the ANA group, and significantly lower in the AA group as compared to the NANA group. The basal expression of Giα-3 was significantly greater (3-15 fold) than Gsα, with no significant difference between any of the three groups. Both cytokines IL-1β and TNF-α significantly decreased the expression of Gsα in the CD4+ cells of the NANA and ANA groups, with no effect in the AA group. However, these cytokines increased the expression of Giα-3, proteins in the AA group, but had no effect in the CD4+ cells of the NANA and ANA groups. These data suggest that a decreased response to β2agonists in the late allergic response in allergis asthmatic subjects could be due to the release of inflammatory cytokines, which induce a decrease in the stimulatory G-proteins and an increase in the inhibitory G-proteins.

AB - Chronic use of β2-agonists and increased production of inflammatory mediators during the late allergic reaction after the antigen challenge result in the desensitization of β-adrenoceptors in the airways with an accompanying rise in non-specific airway hyperresponsiveness. Several proinflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), play a significant role in orchestrating and perpetuating the inflammatory response and induce the decreased response to bronchodilators in vitro. However, the underlying mechanisms are unknown. In this study, we examined the effect of two cytokines, IL-1β and TNF-α, on the expression of guanine nucleotide binding regulatory proteins (G-proteins), Gsα and Giα-3, by Western blotting in the CD4+ cells of nonatopic nonasthmatic (NANA), atopic nonasthmatic (ANA), and atopic asthmatic (AA) subjects. In the purified CD4+ cells, the basal expression of Gsα was higher in the ANA group, and significantly lower in the AA group as compared to the NANA group. The basal expression of Giα-3 was significantly greater (3-15 fold) than Gsα, with no significant difference between any of the three groups. Both cytokines IL-1β and TNF-α significantly decreased the expression of Gsα in the CD4+ cells of the NANA and ANA groups, with no effect in the AA group. However, these cytokines increased the expression of Giα-3, proteins in the AA group, but had no effect in the CD4+ cells of the NANA and ANA groups. These data suggest that a decreased response to β2agonists in the late allergic response in allergis asthmatic subjects could be due to the release of inflammatory cytokines, which induce a decrease in the stimulatory G-proteins and an increase in the inhibitory G-proteins.

UR - http://www.scopus.com/inward/record.url?scp=0036024619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036024619&partnerID=8YFLogxK

U2 - 10.1081/JAS-120004037

DO - 10.1081/JAS-120004037

M3 - Article

C2 - 12214898

AN - SCOPUS:0036024619

VL - 39

SP - 441

EP - 448

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 5

ER -